The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers.
 
William Joseph Chapin
No Relationships to Disclose
 
Parul Agarwal
No Relationships to Disclose
 
Lisa DiCicco
No Relationships to Disclose
 
Rayleigh Palmer
No Relationships to Disclose
 
Nadia Cenou
No Relationships to Disclose
 
Alexander Chan Chi Huang
Consulting or Advisory Role - Immunai
Research Funding - Bristol-Myers Squibb
 
Thomas Benjamin Karasic
Honoraria - AstraZeneca/MedImmune; Incyte; Ipsen; Pfizer; Taiho Oncology
Consulting or Advisory Role - Incyte; Nucorion Pharmaceuticals
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); H3 Biomedicine (Inst); Incyte (Inst); Lilly (Inst); Taiho Pharmaceutical (Inst); Tempest Therapeutics (Inst); Xencor (Inst)